New delta-opioid antagonists as pharmacological probes.
Bryant
S D
SD
National Institute of Environmental Health Sciences, Research Triangle Park, NC 22709, USA.
Salvadori
S
S
Cooper
P S
PS
Lazarus
L H
LH
D003001:Cloning, Molecular; D015195:Drug Design; D008024:Ligands; D008968:Molecular Conformation; D009292:Narcotic Antagonists / Q000494:pharmacology*; D009842:Oligopeptides / Q000494:pharmacology; D009293:Opioid-Related Disorders / Q000235:genetics; D017465:Receptors, Opioid, delta / Q000037:antagonists & inhibitors* / Q000235:genetics; D017473:Receptors, Opioid, kappa / Q000037:antagonists & inhibitors; D017450:Receptors, Opioid, mu / Q000037:antagonists & inhibitors; D044005:Tetrahydroisoquinolines
D008024:Ligands; D009292:Narcotic Antagonists; D009842:Oligopeptides; D017465:Receptors, Opioid, delta; D017473:Receptors, Opioid, kappa; D017450:Receptors, Opioid, mu; D044005:Tetrahydroisoquinolines; C082263:tyrosyl-1,2,3,4-tetrahydro-3-isoquinolinecarbonyl-phenylalanyl-phenylalanine